Press Enter for full results
, functional medicine researcher, data analyst, peptide specialist

, functional medicine researcher, data analyst, peptide specialist , functional medicine researcher, data analyst, peptide specialist

Marcus Reid is a functional medicine researcher, data analyst, and peptide specialist, and one of the people who built MyPeptidePal. The platform exists in part because of the years he spent immersed in clinical literature, real-world protocols, and the kind of hands-on experimentation that most textbooks skip entirely. He is not a physician and does not pretend to be. What he is, is someone who has done the work to understand how these compounds actually function at a biological level, what the research actually says versus what the forums claim, and how to explain it in a way that makes sense to anyone willing to learn. At MPP, Marcus contributed to building the knowledge base, the protocol frameworks, and the research systems that power the platform. His work covers tissue repair, metabolic health, hormonal optimization, longevity, cognitive function, and cosmetic applications. When the science gets complicated, his job is to make it click.

Articles by , functional medicine researcher, data analyst, peptide specialist

7 Best Peptides for Antimicrobial Use

The antimicrobial peptide field spans two genuinely different worlds: FDA-approved peptide antibiotics used in hospitals for serious infections, and endogenous or research-stage compounds being explored and discussed by biohackers and off-label users. This guide covers seven peptides people are actually using or actively discussing for antimicrobial purposes, from clinical mainstays like vancomycin and daptomycin to research-stage compounds like LL-37 and omiganan, giving each an honest account of what it is, how it is used, and where the evidence actually stands. The entries are ordered by how prominently each compound appears in research and documented real-world use, not ranked as recommendations from one being better than another.

Antimicrobial 10 min read

7 Best Peptides for Longevity

Seven peptides show up consistently when people research longevity and healthy aging: GLP-1 receptor agonists like semaglutide, which carry the strongest human trial data in the field; Epitalon, the most-discussed compound for telomere biology; Thymosin Alpha-1, approved in dozens of countries for immune conditions with a real clinical record behind it; and several others ranging from GHK-Cu to MOTS-c and BPC-157 that sit at various points on the evidence spectrum. This guide covers each one in turn, explaining what it is, how people use it for longevity, and what the evidence actually shows, from published trials to community-reported experience. The compounds are ordered by how prominently they appear in research and real-world use, not ranked as recommendations; the right choice depends on your specific situation, and building a personalized plan is what MyPeptidePal is for.

Longevity 12 min read

7 Best Peptides for Anti-Aging

Anti-aging is one of the most active areas in peptide research, spanning topical compounds with solid human trial data and injected or systemic peptides whose evidence is still largely preclinical. This guide covers seven peptides people most prominently use and discuss for anti-aging goals, from topical signal peptides to systemic and immune-focused compounds, with an honest account of what each one does and where the evidence actually stands. The compounds are ordered by how prominently each appears in research and real-world use, not ranked as one being better than another for any individual. Working out which option fits your specific situation is exactly what MyPeptidePal is built to help with.

Anti Aging 11 min read

6 Best Peptides for Dementia

Six peptides come up consistently when people research cognitive support for dementia: Cerebrolysin, Semax, Cortexin, Dihexa, Pinealon, and P21. They range from compounds with genuine human trial data used clinically in parts of Europe and Asia to research chemicals whose evidence base is entirely animal models or community-reported experience. None is FDA-approved for dementia, and none replaces evaluated medical care. This guide covers each one in plain language, what it is, how people use it for dementia, and what the evidence actually shows. The compounds are numbered by how prominently each appears in research and real-world use, not ranked as personal recommendations, and turning any of these options into a personalized plan is exactly what the MyPeptidePal app is built to do.

Neurodegenerative Diseases 10 min read

7 Best Peptides for Immunomodulation

Immunomodulation is one of the most active areas in peptide research, and a meaningful number of compounds are being used or actively discussed for their ability to tune immune function, whether that means calming chronic inflammation, rebuilding a depleted immune system, or supporting the body's adaptive response to infection. This guide covers seven peptides that appear most prominently in research and real-world use for this goal: Thymosin Alpha-1, BPC-157, TB-500, LL-37, GHK-Cu, Selank, and KPV. They are ordered by how prominently each shows up in research and real-world use, not ranked as a recommendation of one over another, and the evidence ranges from decades of randomized controlled trials to early animal data and community-reported experience with no clinical trial backing yet.

Immunomodulation 12 min read

7 Best Peptides for Immune System Support

Seven peptides consistently come up when people research immune system support, and the field spans a wide range of evidence. Thymosin Alpha-1 stands apart as the only compound with multiple randomized controlled trials behind it and regulatory approval in more than 35 countries, while compounds like BPC-157, GHK-Cu, and Thymalin are widely used in the community but rest on animal research, mechanistic data, or clinical experience from outside the United States rather than Western human trials. This guide covers each compound honestly, including those whose evidence is experiential rather than clinical. The entries are numbered by how prominently each appears in research and real-world use, not as a ranking of one being better than another for any individual situation.

Immune System Support 11 min read

7 Best Peptides for Alzheimer's

When people search for the best peptides for Alzheimer's, they most often encounter Cerebrolysin, Semax, and Selank as the starting point. From there, the conversation extends to investigational compounds: Dihexa, a synaptogenesis-promoting peptide studied in animals; PHDP5, a tau-targeting peptide that released a key transport protein in mouse studies; the CDK5-blocking peptide, a 12-amino-acid synthetic molecule designed to interrupt a hyperactive enzyme that drives neuron damage; and Semaglutide, a GLP-1 hormone approved for diabetes that some researchers associate with reduced Alzheimer's risk. People reach for these compounds because they address real biological targets in the disease, from neurotrophic support to synaptic repair to neuroinflammation. This guide walks through all seven: what each one is, how people use it for cognitive decline, and what the evidence honestly shows. The compounds are ordered by how prominently each appears in research and real-world use, not ranked as a personal recommendation, and the personalized decision belongs in the MyPeptidePal app.

Alzheimers 11 min read

Bioglutide Protocol: How to Cycle It, Timing & What to Expect

A Bioglutide protocol runs as a continuous daily oral capsule with a gradual escalation phase over the first several weeks into a steady maintenance phase, with no structured off-cycle break. Phase 2 trials ran the protocol continuously for 13 weeks, and the general horizon for meaningful metabolic progress is 20 to 24 weeks of consistent daily use. Because this is a continuous-use metabolic compound rather than a cycle-and-rest peptide, any discontinuation is tapered rather than abrupt. The personalized dose within that escalation arc depends on your goal, your tolerance at each step, and your clinical context, and is built in the MyPeptidePal app.

Protocols By Compound 10 min read

Gotratix A18 Protocol: How to Cycle It, Timing & What to Expect

A gotratix A18 protocol runs as a defined course rather than continuous daily use: either a focused 10-day short course or a fuller 30-day course, followed by an off-cycle break of two to six months. The compound is taken orally as a capsule or sublingually as drops before meals, never injected, and where someone lands within the dose range depends on their goal, chosen format, and how frequently courses are repeated across the year. This guide covers the full cycle structure, timing principles, what to expect across the arc of a well-run protocol, and the most common mistakes people make, while the personalized dose and exact cycle structure are built in the MyPeptidePal Protocol Creator.

Protocols By Compound 9 min read

NMN Protocol: How to Cycle It, Timing & What to Expect

An NMN protocol is built around daily oral supplementation taken every morning, with meaningful results assessed after eight to twelve weeks of consistent use. The cycle does not require a traditional loading phase, and off-cycle breaks are optional rather than clinically mandated. Your exact dose depends on your goal, your age, and how your body responds, and it is built in the MyPeptidePal Protocol Creator rather than fixed here.

Protocols By Compound 11 min read

NMNH Protocol: How to Cycle It, Timing & What to Expect

An NMNH protocol runs as a continuous daily oral cycle of 90 days, taken once each morning at a consistent dose with no loading phase and no mandated off-cycle break. The dose is shaped by your goal, your prior experience with NAD+ precursors, and whether you are new to NMNH or transitioning from a related compound. The exact number is built in the MyPeptidePal Protocol Creator rather than fixed for everyone.

Protocols By Compound 9 min read

AKG Protocol: How to Cycle It, Timing & What to Expect

An AKG protocol is a daily oral supplementation cycle, typically structured as 12 weeks of continuous use with no mandatory off-cycle break. Unlike receptor-targeting peptides, alpha-ketoglutarate is an endogenous metabolic molecule your body already produces, so the cycling logic that governs peptide protocols does not apply here. Most people split their daily dose into a morning and afternoon administration to maintain steadier plasma levels given how rapidly AKG is metabolized. The exact dose depends on your goal, the form you are using, and your experience level, and is built for you in the MyPeptidePal Protocol Creator.

Protocols By Compound 10 min read

AC-SDKP Goralatide Protocol: How to Cycle It, Timing & What to Expect

AC-SDKP Goralatide runs as a short, acute treatment window rather than a recurring weekly cycle. The validated structure in research is a 3-day window that begins 48 hours before a hematopoietic stressor, delivered by subcutaneous injection at six to nine administrations across that period, with no established maintenance or off-cycle phase that follows. Because the compound's mechanism and timing requirements differ significantly from most wellness peptides, the personalized dose and schedule are built in the MyPeptidePal Protocol Creator rather than stated here.

Protocols By Compound 10 min read

Larazotide Protocol: How to Cycle It, Timing & What to Expect

A larazotide protocol runs as a continuous daily treatment rather than an on-off cycle, with clinical trials studying treatment periods of 12 to 24 weeks and no cycling break required. The compound is taken orally three times daily, with each dose timed 15 minutes before a meal to align its protective window with active food digestion. Unlike injectable peptides, larazotide works locally in the gut lumen and does not trigger receptor desensitization, so no loading phase and no off-cycle break are built into the protocol. The personalized dose is built in the MyPeptidePal Protocol Creator, which accounts for your goal, your symptom picture, and how you respond.

Protocols By Compound 10 min read

SLU-PP-332+BAM15 Protocol: How to Cycle It, Timing & What to Expect

SLU-PP-332 and BAM15 are two small-molecule compounds often run together as a mitochondrial stack, pairing SLU-PP-332's ability to build mitochondrial capacity with BAM15's fat-burning uncoupling effect. The defining structural feature of this combination is the split-day design: the two compounds are kept on separate days rather than taken together, so the protocol is organized around training-day and rest-day dosing rather than a single daily routine. Most cycles run 8 to 12 weeks, and because neither compound operates through a hormonal feedback loop, a mandatory off-cycle break is not mechanically required, though most practitioners recommend one to reassess baseline. The actual dose for each compound depends on your goal, your experience with thermogenic compounds, and how your body responds, and is built in the MyPeptidePal Protocol Creator rather than guessed from community forums.

Protocols By Compound 11 min read